RxDoctor Payments DataLook up a doctor →

Brian Bruel

Interventional Pain Medicine · Houston, TXNPI 1659563047

Payments from drug & device makers

$219,219in general payments, 2019–2025

Across 1,220 payments — averaging $179.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$80K
  • Boston Scientific$43K
  • Tersera Therapeutics LLC$35K
  • Medtronic$19K
  • Flowonix Medical Incorporated$8K
  • MML US, Inc.$6K
  • plus $29K from 54 others
$372in research payments, 2019–2025

Across 2 payments — averaging $186.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$372

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Saluda Medical Americas, Inc.133$80,241
Boston Scientific101$43,202
Tersera Therapeutics LLC141$34,962
Medtronic(2 entities)88$18,750
Flowonix Medical Incorporated2$7,591
MML US, Inc.58$5,662
Abbott50$3,844
Relievant Medsystems, Inc.69$3,735
AbbVie(2 entities)166$2,963
Spinal Simplicity, LLC37$2,776
Biotronik NRO, Inc.15$2,428
Nevro Corp.24$1,757
Nalu Medical, Inc.16$1,266
Si-bone, Inc.11$1,031
Daiichi Sankyo Inc.7$1,022
Painteq LLC21$896
Merz Pharmaceuticals, LLC39$805
VGI Medical, LLC2$527
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC38$504
Pfizer20$467
Vertiflex, Inc.6$368
Collegium Pharmaceutical, Inc.23$328
Biohaven Pharmaceuticals, Inc.8$314
Globus Medical4$288
Amgen(2 entities)14$269
Foundation Fusion Solutions, LLC1$267
Merz North America, Inc.11$253
Biohaven Pharmaceutical Holding Company Ltd.12$205
Stimwave Technologies Incorporated1$180
Pacira Therapeutics, Inc.11$162
Piramal Critical Care10$160
Averitas Pharma Inc.6$157
SPR Therapeutics, Inc5$127
Acelrx Pharmaceuticals, Inc.1$124
Curonix LLC2$123
Gilead1$122
GRT US Holding, Inc.3$121
Ipsen Biopharmaceuticals, Inc3$96
Vertex3$87
Arbor Pharmaceuticals, Inc.4$84
Biodelivery Sciences International, Inc.6$77
Lilly USA, LLC5$73
Axsome Therapeutics, Inc.2$65
Masimo Corporation3$62
Scilex Pharmaceuticals Inc.3$57
Vertos Medical, Inc.2$56
IBSA Pharma Inc.3$55
Bioventus LLC2$53
Eisai Inc.3$50
Almatica Pharma LLC3$49
Redhill Biopharma Inc.3$46
Azurity Pharmaceuticals, Inc.2$43
Innovation Technologies Inc2$39
Zyla Life Sciences, Inc.2$32
Johnson & Johnson2$28
Idorsia Pharmaceuticals US Inc1$22
Hikma Pharmaceuticals USA1$21
Valinor Pharma, LLC1$18
Electronic Waveform Lab, Inc.1$17
Kowa Pharmaceuticals America, Inc.1$17

How this compares

$219,219 in reported general payments places this provider in the 95th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024
$377,994
Medicare patients
217
Services billed
17,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →